The Relationship Between Hypertension and Inflammation

The summary for the The Relationship Between Hypertension and Inflammation Federal Grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the government agency that is offering this grant.
Federal Grant Title: The Relationship Between Hypertension and Inflammation
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-035
Type of Funding: Grant
CFDA Numbers: 93.837
CFDA Descriptions: Heart and Vascular Diseases Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple dates, see announcement.
Posted Date: Oct 21, 2005
Creation Date: Dec 12, 2006
Archive Date: Feb 03, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Grant Description
This initiative will encourage the study of the sequence of events in which the vascular inflammatory state contributes to the development and maintenance of hypertension. Ample evidence suggests that inflammation may play a role in the pathogenesis of hypertension or that it may characterize a functional state of the vessel wall as a consequence of high blood pressure. Angiotensin II (Ang II), a widely recognized vasoconstrictor and anti-natriuretic involved in blood pressure regulation, also acts as a pro-inflammatory factor in the cardiovascular system. Ang II stimulates the expression of several inflammatory cytokines, which in turn affect blood pressure. A potential linkage between Ang II and immuno-cytokines is their shared ability to induce the level of reactive oxygen species (ROS), which serve as second messengers for many intracellular signaling pathways. The production of ROS not only decreases bioavailability of nitric oxide (NO), a vasodilator, but also initiates the functional and morphological alterations, such as remodeling, in the vascular wall that accompany the hypertensive state over time. This initiative would provide an opportunity to bring focus on the potential causal relationship between hypertension and inflammation in a cohesive, integrated manner. A new understanding of hypertension and inflammation would provide novel opportunities to prevent and treat the disease.
Applicants Eligible for this Grant
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments County governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities State governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible agencies of the Federal government Foreign Institutions
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-06-035.html http://grants.nih.gov/grants/guide/pa-files/PA-06-035.html
Grant Announcement Contact
Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
Similar Government Grants
Cardiovascular Development Consortium (UM1)
Pediatric Cardiac Genomics Consortium (UM1)
Biophysical and Biomechanical Aspects of Embryonic Development (R01)
Biophysical and Biomechanical Aspects of Embryonic Development (R21)
Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity...
Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...
Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
Clinical Research in Peripheral Arterial Disease
More Grants from the National Institutes of Health
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development f...
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development f...
Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School...
Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC...
Mucosal Environment and HIV Prevention (MEHP II) (R01)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com